358 related articles for article (PubMed ID: 25736436)
1. WDFY1 mediates TLR3/4 signaling by recruiting TRIF.
Hu YH; Zhang Y; Jiang LQ; Wang S; Lei CQ; Sun MS; Shu HB; Liu Y
EMBO Rep; 2015 Apr; 16(4):447-55. PubMed ID: 25736436
[TBL] [Abstract][Full Text] [Related]
2. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.
Ahmed S; Maratha A; Butt AQ; Shevlin E; Miggin SM
J Immunol; 2013 Mar; 190(5):2217-28. PubMed ID: 23365087
[TBL] [Abstract][Full Text] [Related]
3. E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation.
Yang Y; Liao B; Wang S; Yan B; Jin Y; Shu HB; Wang YY
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5115-20. PubMed ID: 23479606
[TBL] [Abstract][Full Text] [Related]
4. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
[TBL] [Abstract][Full Text] [Related]
5. Catching the adaptor-WDFY1, a new player in the TLR-TRIF pathway.
Nandakumar R; Paludan SR
EMBO Rep; 2015 Apr; 16(4):397-8. PubMed ID: 25736437
[TBL] [Abstract][Full Text] [Related]
6. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
11. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
[TBL] [Abstract][Full Text] [Related]
12. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling.
Han KJ; Yang Y; Xu LG; Shu HB
J Biol Chem; 2010 Apr; 285(17):12543-50. PubMed ID: 20200155
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
[TBL] [Abstract][Full Text] [Related]
15. Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF-dependent innate immunity.
Liu BM; Li NL; Wang R; Li X; Li ZA; Marion TN; Li K
J Biol Chem; 2024 May; 300(5):107249. PubMed ID: 38556084
[TBL] [Abstract][Full Text] [Related]
16. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.
Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH
Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804
[TBL] [Abstract][Full Text] [Related]
17. MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ
Fitzpatrick JM; Minogue E; Curham L; Tyrrell H; Gavigan P; Hind W; Downer EJ
J Neuroimmunol; 2020 Jun; 343():577217. PubMed ID: 32244040
[TBL] [Abstract][Full Text] [Related]
18. MUC1 regulates epithelial inflammation and apoptosis by PolyI:C through inhibition of Toll/IL-1 receptor-domain-containing adapter-inducing IFN-β (TRIF) recruitment to Toll-like receptor 3.
Kato K; Lillehoj EP; Kim KC
Am J Respir Cell Mol Biol; 2014 Sep; 51(3):446-54. PubMed ID: 24693944
[TBL] [Abstract][Full Text] [Related]
19. Toll/IL-1 domain-containing adaptor inducing IFN-β (TRIF) mediates innate immune responses in murine peritoneal mesothelial cells through TLR3 and TLR4 stimulation.
Hwang EH; Kim TH; Oh SM; Lee KB; Yang SJ; Park JH
Cytokine; 2016 Jan; 77():127-34. PubMed ID: 26579632
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
